HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 547 filers reported holding HORIZON THERAPEUTICS PUB L in Q1 2023. The put-call ratio across all filers is 3.18 and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $92,552 | -28.2% | 800 | -36.2% | 0.00% | 0.0% |
| Q2 2023 | $128,975 | +12.8% | 1,254 | +19.7% | 0.00% | 0.0% |
| Q1 2023 | $114,379 | +103.0% | 1,048 | -29.9% | 0.00% | -50.0% |
| Q4 2022 | $56,331 | -87.0% | 1,494 | -78.7% | 0.00% | -71.4% |
| Q3 2022 | $434,000 | -31.3% | 7,019 | -11.5% | 0.01% | -30.0% |
| Q2 2022 | $632,000 | -29.7% | 7,929 | -4.9% | 0.01% | -28.6% |
| Q4 2021 | $899,000 | -24.4% | 8,340 | -23.1% | 0.01% | -51.7% |
| Q3 2021 | $1,189,000 | +21.8% | 10,850 | +4.1% | 0.03% | +11.5% |
| Q2 2021 | $976,000 | +155.5% | 10,425 | +151.2% | 0.03% | +136.4% |
| Q1 2021 | $382,000 | +26.9% | 4,150 | +0.7% | 0.01% | +10.0% |
| Q4 2020 | $301,000 | +9.1% | 4,121 | +15.9% | 0.01% | 0.0% |
| Q3 2020 | $276,000 | -7.4% | 3,556 | -56.9% | 0.01% | -16.7% |
| Q4 2019 | $298,000 | +26.8% | 8,253 | -4.4% | 0.01% | +20.0% |
| Q3 2019 | $235,000 | +2.2% | 8,630 | -9.8% | 0.01% | -28.6% |
| Q2 2019 | $230,000 | – | 9,570 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |